Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Iovance Biotherapeutics (IOVA) Asset Utilization Ratio (2023 - 2025)

Iovance Biotherapeutics (IOVA) has disclosed Asset Utilization Ratio for 4 consecutive years, with 0.29 as the latest value for Q4 2025.

  • On a quarterly basis, Asset Utilization Ratio changed N/A to 0.29 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.29, a N/A change, with the full-year FY2025 number at 0.29, up 48.91% from a year prior.
  • Asset Utilization Ratio was 0.29 for Q4 2025 at Iovance Biotherapeutics, up from 0.28 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.29 in Q4 2025 to a low of 0.0 in Q2 2023.
  • A 3-year average of 0.13 and a median of 0.11 in 2024 define the central range for Asset Utilization Ratio.
  • Biggest YoY gain for Asset Utilization Ratio was 9719.44% in 2025; the steepest drop was 9719.44% in 2025.
  • Iovance Biotherapeutics' Asset Utilization Ratio stood at 0.0 in 2023, then skyrocketed by 58.43% to 0.0 in 2024, then soared by 12461.07% to 0.29 in 2025.
  • Per Business Quant, the three most recent readings for IOVA's Asset Utilization Ratio are 0.29 (Q4 2025), 0.28 (Q3 2025), and 0.26 (Q2 2025).